Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine

NCT00298753 is registered in ClinicalTrials.gov with Regional Hospital Holstebro as lead sponsor.

NCT NCT00298753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00298753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine
Lead sponsor
Regional Hospital Holstebro
Phase
Phase 4
Overall status
Withdrawn
Start date
May 31, 2005
Completion date
Not reported
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

syndrome of inappropriate adh-secretion